Overview
The Union Minister of State (Independent Charge) for Science & Technology, Dr Jitendra Singh, inaugurated Phase‑III of the BRCP on 15 July 2026. The new phase brings a total outlay of ₹1,500 crore, with ₹1,000 crore from the DBT and ₹500 crore from the UK‑based Wellcome Trust. The programme aims to build a world‑class biomedical research workforce and boost India’s emerging bioeconomy.
Key Developments
- Phase‑III approved by the Union Cabinet, ensuring continuous fellowships and research grants.
- Funding split: ₹1,000 crore from DBT and ₹500 crore from Wellcome Trust.
- More than 500 researchers have been supported since 2008 across 200+ institutions.
- Programme now emphasizes interdisciplinary, team‑based research to translate discoveries into health technologies.
- Calls for greater participation of philanthropic bodies and industry to sustain innovation.
Important Facts
The bioeconomy, defined as the economic activity derived from scientific and technological advances in biology, has grown from USD 10 billion in 2014 to over USD 195 billion in 2025 and is projected to reach USD 300 billion by 2030. India now hosts roughly 12,000 biotechnology startups and is among the world’s leading vaccine manufacturers. The DBT‑Wellcome Trust India Alliance administers the BRCP, linking Indian scientists with global expertise.
Exam Relevance
Understanding the BRCP helps aspirants answer questions on:
- India’s strategy to develop a biotechnology‑led economy.
- Public‑private‑philanthropic partnerships in science and health (relevant to GS3 and GS4).
- Government initiatives that align with the vision of Viksit Bharat 2047.
- Policy measures that encourage research translation, startup incubation, and global collaboration.
Way Forward
To maximise impact, the Ministry plans to:
- Expand interdisciplinary grants that bring together clinicians, basic scientists, and engineers.
- Strengthen links with industry for faster commercialization of diagnostics and therapeutics.
- Invite more international philanthropic partners to diversify funding sources.
- Integrate research outcomes with national health programmes, ensuring affordable solutions for the population.
These steps aim to cement India’s position as a global hub for biomedical innovation and to translate scientific breakthroughs into tangible health benefits for citizens.